|
1
|
Johnson TV, Bull ND, Hunt DP, Marina N,
Tomarev SI and Martin KR: Neuroprotective effects of intravitreal
mesenchymal stem cell transplantation in experimental glaucoma.
Invest Ophthalmol Vis Sci. 51:2051–2059. 2010. View Article : Google Scholar :
|
|
2
|
Matsushita K, Morello F, Wu Y, et al:
Mesenchymal stem cells differentiate into renin-producing
juxtaglomerular (JG)-like cells under the control of liver X
receptor-alpha. J Biol Chem. 285:11974–11982. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Williams AR and Hare JM: Mesenchymal stem
cells: biology, pathophysiology, translational findings, and
therapeutic implications for cardiac disease. Circ Res.
109:923–940. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Musumeci G, Lo Furno D, Loreto C, et al:
Mesenchymal stem cells from adipose tissue which have been
differentiated into chondrocytes in three-dimensional culture
express lubricin. Exp Biol Med (Maywood). 236:1333–1341. 2011.
View Article : Google Scholar
|
|
5
|
Jurewicz M, Yang S, Augello A, et al:
Congenic mesenchymal stem cell therapy reverses hyperglycemia in
experimental type 1 diabetes. Diabetes. 59:3139–3147. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Curley GF, Hayes M, Ansari B, et al:
Mesenchymal stem cells enhance recovery and repair following
ventilator-induced lung injury in the rat. Thorax. 67:496–501.
2012. View Article : Google Scholar
|
|
7
|
Li J, Li D, Liu X, Tang S and Wei F: Human
umbilical cord mesenchymal stem cells reduce systemic inflammation
and attenuate LPS-induced acute lung injury in rats. J Inflamm
(Lond). 9:332012. View Article : Google Scholar
|
|
8
|
Hu KX, Sun QY, Guo M and Ai HS: The
radiation protection and therapy effects of mesenchymal stem cells
in mice with acute radiation injury. Br J Radiol. 83:52–58. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zoja C, Garcia PB, Rota C, et al:
Mesenchymal stem cell therapy promotes renal repair by limiting
glomerular podocyte and progenitor cell dysfunction in
adriamycin-induced nephropathy. Am J Physiol Renal Physiol.
303:F1370–F1381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nauta AJ and Fibbe WE: Immunomodulatory
properties of mesenchymal stromal cells. Blood. 110:3499–3506.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aggarwal S and Pittenger MF: Human
mesenchymal stem cells modulate allogeneic immune cell responses.
Blood. 105:1815–1822. 2005. View Article : Google Scholar
|
|
12
|
Atoui R, Shum-Tim D and Chiu RC:
Myocardial regenerative therapy: immunologic basis for the
potential ‘universal donor cells’. Ann Thorac Surg. 86:327–334.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rice CM, Kemp K, Wilkins A and Scolding
NJ: Cell therapy for multiple sclerosis: an evolving concept with
implications for other neurodegenerative diseases. Lancet.
382:1204–1213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim N, Im KI, Lim JY, et al: Mesenchymal
stem cells for the treatment and prevention of graft-versus-host
disease: experiments and practice. Ann Hematol. 92:1295–1308. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ning H, Yang F, Jiang M, et al: The
correlation between cotransplantation of mesenchymal stem cells and
higher recurrence rate in hematologic malignancy patients: outcome
of a pilot clinical study. Leukemia. 22:593–599. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ball LM, Bernardo ME, Roelofs H, et al:
Cotransplantation of ex vivo expanded mesenchymal stem cells
accelerates lymphocyte recovery and may reduce the risk of graft
failure in haploidentical hematopoietic stem-cell transplantation.
Blood. 110:2764–2767. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lazarus HM, Koc ON, Devine SM, et al:
Cotransplantation of HLA-identical sibling culture-expanded
mesenchymal stem cells and hematopoietic stem cells in hematologic
malignancy patients. Biol Blood Marrow Transplant. 11:389–398.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koç ON, Gerson SL, Cooper BW, et al: Rapid
hematopoietic recovery after coinfusion of autologous-blood stem
cells and culture-expanded marrow mesenchymal stem cells in
advanced breast cancer patients receiving high-dose chemotherapy. J
Clin Oncol. 18:307–316. 2000.PubMed/NCBI
|
|
19
|
Le Blanc K, Samuelsson H, Gustafsson B, et
al: Transplantation of mesenchymal stem cells to enhance
engraftment of hematopoietic stem cells. Leukemia. 21:1733–1738.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ji JF, He BP, Dheen ST and Tay SS:
Interactions of chemokines and chemokine receptors mediate the
migration of mesenchymal stem cells to the impaired site in the
brain after hypoglossal nerve injury. Stem Cells. 22:415–427. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Devine SM, Cobbs C, Jennings M,
Bartholomew A and Hoffman R: Mesenchymal stem cells distribute to a
wide range of tissues following systemic infusion into nonhuman
primates. Blood. 101:2999–3001. 2003. View Article : Google Scholar
|
|
22
|
Jung JW, Kwon M, Choi JC, et al: Familial
occurrence of pulmonary embolism after intravenous, adipose
tissue-derived stem cell therapy. Yonsei Med J. 54:1293–1296. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spaggiari GM, Abdelrazik H, Becchetti F
and Moretta L: MSCs inhibit monocyte-derived DC maturation and
function by selectively interfering with the generation of immature
DCs: central role of MSC-derived prostaglandin E2. Blood.
113:6576–6583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Opitz CA, Litzenburger UM, Lutz C, et al:
Toll-like receptor engagement enhances the immunosuppressive
properties of human bone marrow-derived mesenchymal stem cells by
inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and
protein kinase R. Stem Cells. 27:909–919. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sato K, Ozaki K, Oh I, et al: Nitric oxide
plays a critical role in suppression of T-cell proliferation by
mesenchymal stem cells. Blood. 109:228–234. 2007. View Article : Google Scholar
|
|
26
|
Yoo SW, Chang DY, Lee HS, et al: Immune
following suppression mesenchymal stem cell transplantation in the
ischemic brain is mediated by TGF-β. Neurobiol Dis. 58:249–257.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Djouad F, Charbonnier LM, Bouffi C, et al:
Mesenchymal stem cells inhibit the differentiation of dendritic
cells through an interleukin-6-dependent mechanism. Stem Cells.
25:2025–2032. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Németh K, Leelahavanichkul A, Yuen PS, et
al: Bone marrow stromal cells attenuate sepsis via prostaglandin
E(2)-dependent reprogramming of host macrophages to increase their
interleukin-10 production. Nat Med. 15:42–49. 2009. View Article : Google Scholar
|
|
29
|
Sui W, Hou X, Che W, et al: Hematopoietic
and mesenchymal stem cell transplantation for severe and refractory
systemic lupus erythematosus. Clin Immunol. 148:186–197. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luz-Crawford P, Kurte M, Bravo-Alegria J,
et al: Mesenchymal stem cells generate a
CD4+CD25+Foxp3+ regulatory T cell
population during the differentiation process of Th1 and Th17
cells. Stem Cell Res Ther. 4:652013. View
Article : Google Scholar
|
|
31
|
Spaggiari GM, Capobianco A, Abdelrazik H,
Becchetti F, Mingari MC and Moretta L: Mesenchymal stem cells
inhibit natural killer-cell proliferation, cytotoxicity, and
cytokine production: role of indoleamine 2,3-dioxygenase and
prostaglandin E2. Blood. 111:1327–1333. 2008. View Article : Google Scholar
|
|
32
|
English K, Ryan JM, Tobin L, Murphy MJ,
Barry FP and Mahon BP: Cell contact, prostaglandin E(2) and
transforming growth factor beta 1 play non-redundant roles in human
mesenchymal stem cell induction of CD4+CD25(High)
forkhead box P3+ regulatory T cells. Clin Exp Immunol.
156:149–160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duffy MM, Pindjakova J, Hanley SA, et al:
Mesenchymal stem cell inhibition of T-helper 17
cell-differentiation is triggered by cell-cell contact and mediated
by prostaglandin E2 via the EP4 receptor. Eur J Immunol.
41:2840–2851. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yañez R, Oviedo A, Aldea M, Bueren JA and
Lamana ML: Prostaglandin E2 plays a key role in the
immunosuppressive properties of adipose and bone marrow
tissue-derived mesenchymal stromal cells. Exp Cell Res.
316:3109–3123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pittenger MF and Martin BJ: Mesenchymal
stem cells and their potential as cardiac therapeutics. Circ Res.
95:9–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tamama K, Kawasaki H and Wells A:
Epidermal growth factor (EGF) treatment on multipotential stromal
cells (MSCs). Possible enhancement of therapeutic potential of MSC.
J Biomed Biotechnol. 2010:7953852010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Freyman T, Polin G, Osman H, et al: A
quantitative, randomized study evaluating three methods of
mesenchymal stem cell delivery following myocardial infarction. Eur
Heart J. 27:1114–1122. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schroder K, Hertzog PJ, Ravasi T and Hume
DA: Interferon-gamma: an overview of signals, mechanisms and
functions. J Leukoc Biol. 75:163–189. 2004. View Article : Google Scholar
|
|
39
|
Pfeffer K: Biological functions of tumor
necrosis factor cytokines and their receptors. Cytokine Growth
Factor Rev. 14:185–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu H, Lu K, MacAry PA, et al: Soluble
molecules are key in maintaining the immunomodulatory activity of
murine mesenchymal stromal cells. J Cell Sci. 125:200–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qi Y, Jiang D, Sindrilaru A, et al: TSG-6
released from intradermally injected mesenchymal stem cells
accelerates wound healing and reduces tissue fibrosis in murine
full-thickness skin wounds. J Invest Dermatol. 134:526–537. 2014.
View Article : Google Scholar
|
|
42
|
Prockop DJ: Concise review: two negative
feedback loops place mesenchymal stem/stromal cells at the center
of early regulators of inflammation. Stem Cells. 31:2042–2046.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Selmani Z, Naji A, Zidi I, et al: Human
leukocyte antigen-G5 secretion by human mesenchymal stem cells is
required to suppress T lymphocyte and natural killer function and
to induce CD4+CD25highFOXP3+
regulatory T cells. Stem Cells. 26:212–222. 2008. View Article : Google Scholar
|
|
44
|
Ren G, Zhang L, Zhao X, et al: Mesenchymal
stem cell-mediated immunosuppression occurs via concerted action of
chemokines and nitric oxide. Cell Stem Cell. 2:141–150. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chabannes D, Hill M, Merieau E, et al: A
role for heme oxygenase-1 in the immunosuppressive effect of adult
rat and human mesenchymal stem cells. Blood. 110:3691–3694. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Brusko TM, Wasserfall CH, Agarwal A,
Kapturczak MH and Atkinson MA: An integral role for heme
oxygenase-1 and carbon monoxide in maintaining peripheral tolerance
by CD4+CD25+ regulatory T cells. J Immunol.
174:5181–5186. 2005. View Article : Google Scholar : PubMed/NCBI
|
